DWI后循环病灶体积对急性基底动脉闭塞血管内治疗后90天临床结局的预测价值:一项回顾性单中心研究
回顾性分析110例经MRI筛选并接受血管内治疗的急性基底动脉闭塞患者,在ADC图上测量治疗前后循环病灶体积(PCLV),中位值4.4 ml(IQR 1.3–21.2 ml)。PCLV是90天功能独立和死亡的独立预测因子,基线PCLV≤8.7 ml预测功能独立的AUC为0.68(敏感度88.6%、特异度49.3%),PCLV≥9.1 ml预测死亡的AUC为0.71(敏感度80%、特异度60%)。
要点
- 基线PCLV中位4.4 ml,是90天功能独立(OR 0.57)和死亡(OR 1.84)的独立预测因子。
- PCLV≤8.7 ml预测90天功能独立:AUC 0.68,敏感度88.6%,特异度49.3%。
- PCLV≥9.1 ml预测90天死亡:AUC 0.71,敏感度80%,特异度60%。
核心结论
- 治疗前PCLV是急性基底动脉闭塞患者90天结局的独立预测因子,PCLV≤8.7 ml和≥9.1 ml可能分别识别出90天更可能达到功能独立和死亡风险更高的患者。
研究设计与样本
- 回顾性单中心研究,纳入110例经MRI筛选并接受血管内治疗的急性基底动脉闭塞患者,在表观扩散系数图重建上以毫升为单位测量基线后循环病灶体积(PCLV),采用单变量和多变量逻辑回归模型检验其预测价值,并用受试者工作特征(ROC)分析确定最佳截断值。
诊断标准与关键数值
- 基线PCLV≤8.7 ml预测90天功能独立(mRS≤2):AUC 0.68(95%CI 0.57–0.79),敏感度88.6%,特异度49.3%。
- PCLV≥9.1 ml预测90天死亡:AUC 0.71(95%CI 0.61–0.82),敏感度80%,特异度60%。
- PCLV对功能独立的OR为0.57(95%CI 0.34–0.93),对死亡的OR为1.84(95%CI 1.23–2.76)。
临床应用与阅片要点
- 在血管内治疗前,可基于ADC图测量后循环病灶体积(PCLV),以毫升为单位记录。
- PCLV≤8.7 ml与90天功能独立可能性较高相关,PCLV≥9.1 ml与90天死亡风险较高相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The relationship between posterior-circulation lesion volume (PCLV) and clinical outcomes is poorly investigated. We aimed to analyze, in patients with acute basilar artery occlusion (ABAO), if pre-endovascular treatment (EVT) PCLV was a predictor of outcomes.
METHODS: We analyzed consecutive MRI selected, endovascularly treated ABAO patients. Baseline PCLV was measured in milliliters on apparent diffusion-coefficient map reconstruction. Univariable and multivariable logistic models were used to test if PCLV was a predictor of 90-day outcomes. After the received operating characteristic (ROC) analysis, the optimal cut-off was determined to evaluate the prognostic value of PCLV.
RESULTS: A total of 110 ABAO patients were included. The median PCLV was 4.4 ml (interquartile range, 1.3-21.2 ml). Successful reperfusion was achieved in 81.8% of cases after EVT. At 90 days, 31.8% of patients had a modified Rankin scale ≤ 2, and the mortality rate was 40.9%. PCLV was an independent predictor of functional independence and mortality (odds ratio [OR]:0.57, 95% confidence interval [CI], 0.34-0.93 and 1.84, 95% CI, 1.23-2.76, respectively). The ROC analysis showed that a baseline PCLV ≤ 8.7 ml was the optimal cut-off to predict the 90-day functional independence (area under the curve [AUC] = 0.68, 95% CI, 0.57-0.79, sensitivity 88.6%, and specificity 49.3%). In addition, a PCLV ≥ 9.1 ml was the optimal cut-off for the prediction of 90-day mortality (AUC = 0.71, 95% CI, 0.61-0.82, sensitivity 80%, and specificity 60%).
CONCLUSIONS: Pre-treatment PCLV was an independent predictor of 90-day outcomes in ABAO. A PCLV ≤ 8.7 and ≥ 9.1 ml may identify patients with a higher possibility to achieve independence and a higher risk of death at 90 days, respectively.
引用
- Mourand I, Mahmoudi M, Lebars E, et al. Predictive value of DWI posterior-circulation lesion volume for 90-day clinical outcome after endovascular treatment of acute basilar artery occlusion: a retrospective single-center study. Neuroradiology. 2021. PMID: 34825967. doi:10.1007/s00234-021-02849-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。